D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ANAB holding history
Anaptysbio, Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANAB overviewAll 13F holders of ANABFull Q2 2026 holdings
- Shares (Q2 2026)
- 539,666
- Value
- $36.4M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 539,666 | $36.4M | <0.1% | −39,630−6.8% | Reduced | Holders |
| Q1 2026 | 579,296 | $32.1M | <0.1% | −90,992−13.6% | Reduced | Holders |
| Q4 2025 | 670,288 | $32.5M | <0.1% | +320,928+91.9% | Added | Holders |
| Q3 2025 | 349,360 | $10.7M | <0.1% | +237,011+211.0% | Added | Holders |
| Q2 2025 | 112,349 | $2.49M | <0.1% | −17,305−13.3% | Reduced | Holders |
| Q1 2025 | 129,654 | $2.41M | <0.1% | −67,453−34.2% | Reduced | Holders |
| Q4 2024 | 197,107 | $2.61M | <0.1% | −27,030−12.1% | Reduced | Holders |
| Q3 2024 | 224,137 | $7.51M | <0.1% | +52,687+30.7% | Added | Holders |
| Q2 2024 | 171,450 | $4.30M | <0.1% | −15,354−8.2% | Reduced | Holders |
| Q1 2024 | 186,804 | $4.21M | <0.1% | +26,478+16.5% | Added | Holders |
| Q4 2023 | 160,326 | $3.43M | <0.1% | +14,434+9.9% | Added | Holders |
| Q3 2023 | 145,892 | $2.62M | <0.1% | −59,904−29.1% | Reduced | Holders |
| Q2 2023 | 205,796 | $4.19M | <0.1% | −1,256−0.6% | Reduced | Holders |
| Q1 2023 | 207,052 | $4.51M | <0.1% | +32,854+18.9% | Added | Holders |
| Q4 2022 | 174,198 | $5.40M | <0.1% | −2,302−1.3% | Reduced | Holders |
| Q3 2022 | 176,500 | $4.50M | <0.1% | +45,348+34.6% | Added | Holders |
| Q2 2022 | 131,152 | $2.66M | <0.1% | −38,408−22.7% | Reduced | Holders |
| Q1 2022 | 169,560 | $4.20M | <0.1% | −43,121−20.3% | Reduced | Holders |
| Q4 2021 | 212,681 | $7.39M | <0.1% | −41,111−16.2% | Reduced | Holders |
| Q3 2021 | 253,792 | $6.88M | <0.1% | −4,852−1.9% | Reduced | Holders |
| Q2 2021 | 258,644 | $6.71M | <0.1% | −36,950−12.5% | Reduced | Holders |
| Q1 2021 | 295,594 | $6.37M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.